TECHNOLOGY - Overview

Galenea has built an integrated neurosciences drug discovery company. We have novel and proprietary technologies in the emerging field of synaptic transmission. These technologies include:

  • MANTRA™ System: sophisticated high-throughput assays of synaptic vesicle cycling and other synaptic functions;
  • Objective Preclinical Measures: preclinical efficacy predictions based on synaptic network activity in animals, as measured by specific and proprietary EEG signatures;
  • Human Biomarkers: neuropsychiatric clinical biomarkers based on synaptic network activity in humans, as measured by human correlates of the EEG signatures identified in animals.

We also have full drug discovery capabilities focused on neuroscience diseases, including behavioral pharmacology, medicinal chemistry, cell-based and biochemical screens, computational sciences and extensive neuroscience biology expertise.

neuron